You are now leaving College Media Network to visit

The Sidelines

(If your pop-up blocker is activated, please click on the link above.)

FDA panel backs experimental hepatitis drug

By: Associated Press

WASHINGTON (AP) and – Federal health experts are recommending approval for a highly anticipated drug from Merck to treat hepatitis C, based on studies showing it cures patients at a higher rate than drugs used for over 20 years.